Rankings
▼
Calendar
OCGN Q1 2021 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$7M
Net Income
-$7M
EPS (Diluted)
$-0.04
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$833,000
Balance Sheet
Total Assets
$54M
Total Liabilities
$7M
Stockholders' Equity
$46M
Cash & Equivalents
$45M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$7M
-$4M
-79.6%
Net Income
-$7M
-$4M
-79.4%
← FY 2021
All Quarters
Q2 2021 →